首页> 美国卫生研究院文献>Tropical Medicine and Infectious Disease >A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
【2h】

A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire

机译:对科特迪瓦两个血吸虫病地方病社区中吡喹酮治疗依从性的影响因素进行快速评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Over the past decade, a significant reduction in the prevalence of schistosomiasis has been achieved, partially explained by the large-scale administration of praziquantel. Yet, the burden of schistosomiasis remains considerable, and factors influencing intervention coverage are important. This study aimed to deepen the understanding of low treatment coverage rates observed in two schistosomiasis-endemic villages in Côte d’Ivoire. The research was conducted in August 2015, in Moronou and Bigouin, two villages of Côte d’Ivoire that are endemic for Schistosoma haematobium and S. mansoni, respectively. After completion of a clinical trial, standard praziquantel treatment (single 40 mg/kg oral dose) was offered to all village inhabitants by community health workers using a house-to-house approach. Factors influencing treatment coverage were determined by a questionnaire survey, randomly selecting 405 individuals. The overall treatment coverage rate was only 47.6% (2730/5733) with considerable intervillage heterogeneity (27.7% in Bigouin (302/1091) versus 52.3% in Moronou (2428/4642)). Among the 200 individuals interviewed in Moronou, 50.0% were administered praziquantel, while only 19.5% of the 205 individuals interviewed in Bigouin received praziquantel. The main reasons for low treatment coverage were work-related (agricultural activities), the bitter taste of praziquantel and previous experiences with adverse events. The most suitable period for treatment campaigns was reported to be the dry season. More than three-quarter of the interviewees who had taken praziquantel (overall, 116/140; Moronou, 84/100; Bigouin, 32/40) declared that they would not participate in future treatments (p < 0.001). In order to enhance praziquantel treatment coverage, careful consideration should be given to attitudes and practices, such as prior or perceived adverse events and taste of praziquantel, and appropriate timing, harmonized with agricultural activities. Without such understanding, breaking the transmission of schistosomiasis remains a distant goal.
机译:在过去的十年中,血吸虫病的发生率已大大降低,部分原因是吡喹酮的大规模给药。然而,血吸虫病的负担仍然很大,影响干预范围的因素很重要。这项研究旨在加深对在科特迪瓦两个血吸虫病流行村庄观察到的低治疗覆盖率的了解。这项研究于2015年8月在科特迪瓦的两个村庄莫罗努和比戈因进行,这两个村庄分别是血吸虫和曼氏沙门氏菌的地方病。在完成一项临床试验后,社区卫生工作者采用逐户方式向所有村民提供了标准吡喹酮治疗(单次口服剂量40 mg / kg)。通过问卷调查确定影响治疗覆盖率的因素,随机选择405个人。总体治疗覆盖率仅为47.6%(2730/5733),且村间异质性相当高(比戈因(302/1091)为27.7%,而莫罗努(2428/4642)为52.3%)。在Moronou采访的200个人中,有50.0%的患者服用吡喹酮,而在Bigouin接受采访的205个人中,只有19.5%接受了吡喹酮。治疗覆盖率低的主要原因是与工作有关的(农业活动),吡喹酮的苦味和以前的不良事件经历。据报道,最适合进行治疗的时期是旱季。接受吡喹酮治疗的受访者中,超过四分之三(总体为116/140; Moronou为84/100; Bigouin为32/40)表示他们将不参加以后的治疗(p <0.001)。为了扩大吡喹酮治疗的覆盖面,应认真考虑态度和做法,例如先前或可感知的不良事件和吡喹酮的味道,以及与农业活动相协调的适当时机。没有这样的理解,打破血吸虫病的传播仍然是遥远的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号